Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus remimazolam crossover study of sleep quality and sleep structure in healthy volunteers
ChiCTR2200060167Phase 4Recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of propofol and remimazolam in sleep disorder (2 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: Sleep structure. Started Jan 2021; status: recruiting.
02
Drugs
propofolremimazolam
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ChiCTR2200060167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060167.